Professional Documents
Culture Documents
(MUL) Management in Colorectal Obstruction
(MUL) Management in Colorectal Obstruction
MANAGEMENT OF COLORECTAL
CANCER
Dr. dr. I Made Mulyawan, Sp.B, Subsp.BD (K)
INTRODUCTION
Kanker Kolorektal
• Kanker yang dijumpai pada kolon dan
rektum.
• Salah satu kanker yang sering dijumpai di
seluruh dunia.
• Kejadiannya rendah beberapa dekade lalu.
• Sebagian besar pada usia > 50 tahun (75%
kanker rektal dan 80% kanker kolon pada
usia ≥ 60 tahun saat diagnosis).
• Lebih sering pada pria.
• Diperkirakan meningkat menjadi 2,5 juta
kasus pada tahun 2035.
Dekker E, Tanis PJ, et al. Lancet 2019;394:1467-80; Granados-Romero JJ, et al. Int J Res Med Sci. 2017;5(11):4667-76; Marmol I, et al. Int J
Mol Sci. 2017;18:197; Sawicki T, et al. Cancers 2021;13:2025; Kuipers EJ, et al. Nat Rev Dis Primers 2016;1:15065
Epidemiologi di Indonesia
20XX
• Most common location of obstructing CRC is sigmoid colon
- 75 % of tumors located distal to splenic flexure
• Perforation at tumor in 70%, and proximal to tumor in 30%
- Perforation at tumor site, contamination often localized
- Perforation proximal, can result in diffuse peritonitis, septic
shock
• Competency of ileocecal valve is critical
- Competent valve results in closed loop obstruction
EMERGENT MANAGEMENT
Contrast Enema
Water soluble (Gastrografin)
Birds beak, apple core
Insight into role of endoscopic stenting (length / severity of
stricture)
Decreased short term morbidity, lower rates of temporary and permanent stoma formation
Analysis of tumor recurrence rate raises concerns about oncologic safety
LEFT SIDED LESIONS
17
MANAGEMENT COLON CANCER :
ESMO
18
CONCLUSIONS
Emergent management of obstructing colorectal cancer
Sepsis control
Resection with oncologic principles
Likely end ileostomy or colostomy formation
Non Emergent management of obstructing colorectal cancer
Resection with oncologic principles
Primary anastomosis if condition warrant
Consider SEMS as BTS with short interval resection at high volume centers
Loop transverse colostomy / blowhole for extraperitoneal cancers
Need to consider need for adjuvant therapy with management decisions
MATUR SUKSMA